These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9520960)

  • 21. Medical utilization associated with palivizumab compliance in a commercial and managed medicaid health plan.
    Diehl JL; Daw JR; Coley KC; Rayburg R
    J Manag Care Pharm; 2010; 16(1):23-31. PubMed ID: 20044844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults.
    Pauly NJ; Brown JD
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1162-70. PubMed ID: 26679965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting.
    Yood RA; Harrold LR; Fish L; Cernieux J; Emani S; Conboy E; Gurwitz JH
    Arch Intern Med; 2001 May; 161(10):1322-7. PubMed ID: 11371261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patterns of Glaucoma Medication Adherence over Four Years of Follow-Up.
    Newman-Casey PA; Blachley T; Lee PP; Heisler M; Farris KB; Stein JD
    Ophthalmology; 2015 Oct; 122(10):2010-21. PubMed ID: 26319441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient persistency with topical ocular hypotensive therapy in a managed care population.
    Reardon G; Schwartz GF; Mozaffari E
    Am J Ophthalmol; 2004 Jan; 137(1 Suppl):S3-12. PubMed ID: 14697909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for noncompliance in a colposcopy clinic.
    Eger RR; Peipert JF
    J Reprod Med; 1996 Sep; 41(9):671-4. PubMed ID: 8887192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prescription noncompliance due to cost among adults with disabilities in the United States.
    Kennedy J; Erb C
    Am J Public Health; 2002 Jul; 92(7):1120-4. PubMed ID: 12084695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for noncompliance with glaucoma follow-up visits in a residents' eye clinic.
    Kosoko O; Quigley HA; Vitale S; Enger C; Kerrigan L; Tielsch JM
    Ophthalmology; 1998 Nov; 105(11):2105-11. PubMed ID: 9818613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Out-of-plan pharmacy use by members of a managed care organization.
    Delate T; Albrecht G; Olson KL
    Perm J; 2012; 16(2):15-21. PubMed ID: 22745611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for noncompliance with follow-up among normal-tension glaucoma suspects.
    Ngan R; Lam DL; Mudumbai RC; Chen PP
    Am J Ophthalmol; 2007 Aug; 144(2):310-1. PubMed ID: 17659968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glaucoma medication adherence in veterans and influence of coexisting chronic disease.
    Asefzadeh B; Rett D; Pogoda TK; Selvin G; Cavallerano A
    J Glaucoma; 2014; 23(4):240-5. PubMed ID: 24522105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Administrative claims analysis of utilization and costs of care in health plan members with atopic dermatitis who had prior use of a topical corticosteroid and who initiate therapy with pimecrolimus or tacrolimus.
    Delea TE; Gokhale M; Makin C; Hussein MA; Vanderpoel J; Sandman T; Chang J; Sung J; Pinkston P; Gause D; Jackson M
    J Manag Care Pharm; 2007 May; 13(4):349-59. PubMed ID: 17506601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review.
    Olthoff CM; Schouten JS; van de Borne BW; Webers CA
    Ophthalmology; 2005 Jun; 112(6):953-61. PubMed ID: 15885795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large Disparities in Receipt of Glaucoma Care between Enrollees in Medicaid and Those with Commercial Health Insurance.
    Elam AR; Andrews C; Musch DC; Lee PP; Stein JD
    Ophthalmology; 2017 Oct; 124(10):1442-1448. PubMed ID: 28583710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance Organization.
    Law SK; Song BJ; Fang E; Caprioli J
    Ophthalmology; 2005 Dec; 112(12):2123-30. PubMed ID: 16225924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilization and costs for compliant patients initiating therapy with pioglitazone or rosiglitazone versus insulin in a Medicaid fee-for-service population.
    Kalsekar I; Iyer S; Mody R; Rajagopalan R; Kavookjian J
    J Manag Care Pharm; 2006 Mar; 12(2):121-9. PubMed ID: 16515370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of the introduction of generic latanoprost on glaucoma medication adherence.
    Stein JD; Shekhawat N; Talwar N; Balkrishnan R
    Ophthalmology; 2015 Apr; 122(4):738-47. PubMed ID: 25680226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO.
    Nag SS; Daniel GW; Bullano MF; Kamal-Bahl S; Sajjan SG; Hu H; Alexander C
    J Manag Care Pharm; 2007 Oct; 13(8):652-63. PubMed ID: 17970603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescription noncompliance: contribution to emergency department visits and cost.
    Olshaker JS; Barish RA; Naradzay JF; Jerrard DA; Safir E; Campbell L
    J Emerg Med; 1999; 17(5):909-12. PubMed ID: 10499716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of clinical, service, and cost outcomes of a conversion program of sumatriptan to rizatriptan ODT in primary care patients with migraine headaches.
    Gershovich OE; Billups SJ; Delate T; Hoffman CK; Carroll N
    J Manag Care Pharm; 2006 Apr; 12(3):246-53. PubMed ID: 16623609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.